Post-transplant persistent lymphopenia is a strong predictor of late survival in isolated intestine and multivisceral transplantation

Shunji Nagai, Richard Mangus, Eve Anderson, Burcin Ekser, Chandrashekhar A. Kubal, Tracy Burch, Jonathan A. Fridell, A. Joseph Tector

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Absolute lymphocyte count (ALC) has been identified as a prognostic factor in liver transplantation. We hypothesized that a lower ALC may be linked to poor outcomes in isolated intestinal/multivisceral transplantation (IIT/MVT). The aim of this study was to investigate the prognostic impact of ALC in IIT/MVT. A total 141 IIT/MVT patients were eligible for the study. Post-transplant ALCs (at 3, 6, and 12 months) were evaluated, and prognostic impact of trend of ALC during the first year was investigated. Of these 141 patients, 108 patients survived in the first year (1-year survivors). One-year survivors were categorized according to post-transplant ALC at each time point. When ALC was decreased throughout the first year (post-transplant persistent lymphopenia: <500/μl at 3, 6, and 12 months), patient survival (P < 0.001, hazard ratio = 5.09) and graft survival (P < 0.001, hazard ratio = 5.15) after the first year was significantly worse, and this remained to be an independent risk factor. Negative impact of persistent lymphopenia on patient and graft survival was significant regardless of type of intestinal graft. Infection leading to mortality occurred more frequently in the persistent lymphopenia group (43% vs. 24%). Trend of post-transplant ALC may be a strong predictive marker for long-term outcome in 1-year survivors after IIT/MVT.

Original languageEnglish
Pages (from-to)1195-1204
Number of pages10
JournalTransplant International
Volume28
Issue number10
DOIs
StatePublished - Oct 1 2015

Fingerprint

Lymphopenia
Lymphocyte Count
Intestines
Transplantation
Transplants
Survival
Survivors
Graft Survival
Liver Transplantation
Mortality
Infection

Keywords

  • absolute lymphocyte count
  • graft survival
  • infection
  • nutrition
  • patient survival

ASJC Scopus subject areas

  • Transplantation

Cite this

Post-transplant persistent lymphopenia is a strong predictor of late survival in isolated intestine and multivisceral transplantation. / Nagai, Shunji; Mangus, Richard; Anderson, Eve; Ekser, Burcin; Kubal, Chandrashekhar A.; Burch, Tracy; Fridell, Jonathan A.; Tector, A. Joseph.

In: Transplant International, Vol. 28, No. 10, 01.10.2015, p. 1195-1204.

Research output: Contribution to journalArticle

Nagai, Shunji ; Mangus, Richard ; Anderson, Eve ; Ekser, Burcin ; Kubal, Chandrashekhar A. ; Burch, Tracy ; Fridell, Jonathan A. ; Tector, A. Joseph. / Post-transplant persistent lymphopenia is a strong predictor of late survival in isolated intestine and multivisceral transplantation. In: Transplant International. 2015 ; Vol. 28, No. 10. pp. 1195-1204.
@article{7ad870f8914e41a4a847b0db94c0a153,
title = "Post-transplant persistent lymphopenia is a strong predictor of late survival in isolated intestine and multivisceral transplantation",
abstract = "Absolute lymphocyte count (ALC) has been identified as a prognostic factor in liver transplantation. We hypothesized that a lower ALC may be linked to poor outcomes in isolated intestinal/multivisceral transplantation (IIT/MVT). The aim of this study was to investigate the prognostic impact of ALC in IIT/MVT. A total 141 IIT/MVT patients were eligible for the study. Post-transplant ALCs (at 3, 6, and 12 months) were evaluated, and prognostic impact of trend of ALC during the first year was investigated. Of these 141 patients, 108 patients survived in the first year (1-year survivors). One-year survivors were categorized according to post-transplant ALC at each time point. When ALC was decreased throughout the first year (post-transplant persistent lymphopenia: <500/μl at 3, 6, and 12 months), patient survival (P < 0.001, hazard ratio = 5.09) and graft survival (P < 0.001, hazard ratio = 5.15) after the first year was significantly worse, and this remained to be an independent risk factor. Negative impact of persistent lymphopenia on patient and graft survival was significant regardless of type of intestinal graft. Infection leading to mortality occurred more frequently in the persistent lymphopenia group (43{\%} vs. 24{\%}). Trend of post-transplant ALC may be a strong predictive marker for long-term outcome in 1-year survivors after IIT/MVT.",
keywords = "absolute lymphocyte count, graft survival, infection, nutrition, patient survival",
author = "Shunji Nagai and Richard Mangus and Eve Anderson and Burcin Ekser and Kubal, {Chandrashekhar A.} and Tracy Burch and Fridell, {Jonathan A.} and Tector, {A. Joseph}",
year = "2015",
month = "10",
day = "1",
doi = "10.1111/tri.12620",
language = "English",
volume = "28",
pages = "1195--1204",
journal = "Transplant International",
issn = "0934-0874",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Post-transplant persistent lymphopenia is a strong predictor of late survival in isolated intestine and multivisceral transplantation

AU - Nagai, Shunji

AU - Mangus, Richard

AU - Anderson, Eve

AU - Ekser, Burcin

AU - Kubal, Chandrashekhar A.

AU - Burch, Tracy

AU - Fridell, Jonathan A.

AU - Tector, A. Joseph

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Absolute lymphocyte count (ALC) has been identified as a prognostic factor in liver transplantation. We hypothesized that a lower ALC may be linked to poor outcomes in isolated intestinal/multivisceral transplantation (IIT/MVT). The aim of this study was to investigate the prognostic impact of ALC in IIT/MVT. A total 141 IIT/MVT patients were eligible for the study. Post-transplant ALCs (at 3, 6, and 12 months) were evaluated, and prognostic impact of trend of ALC during the first year was investigated. Of these 141 patients, 108 patients survived in the first year (1-year survivors). One-year survivors were categorized according to post-transplant ALC at each time point. When ALC was decreased throughout the first year (post-transplant persistent lymphopenia: <500/μl at 3, 6, and 12 months), patient survival (P < 0.001, hazard ratio = 5.09) and graft survival (P < 0.001, hazard ratio = 5.15) after the first year was significantly worse, and this remained to be an independent risk factor. Negative impact of persistent lymphopenia on patient and graft survival was significant regardless of type of intestinal graft. Infection leading to mortality occurred more frequently in the persistent lymphopenia group (43% vs. 24%). Trend of post-transplant ALC may be a strong predictive marker for long-term outcome in 1-year survivors after IIT/MVT.

AB - Absolute lymphocyte count (ALC) has been identified as a prognostic factor in liver transplantation. We hypothesized that a lower ALC may be linked to poor outcomes in isolated intestinal/multivisceral transplantation (IIT/MVT). The aim of this study was to investigate the prognostic impact of ALC in IIT/MVT. A total 141 IIT/MVT patients were eligible for the study. Post-transplant ALCs (at 3, 6, and 12 months) were evaluated, and prognostic impact of trend of ALC during the first year was investigated. Of these 141 patients, 108 patients survived in the first year (1-year survivors). One-year survivors were categorized according to post-transplant ALC at each time point. When ALC was decreased throughout the first year (post-transplant persistent lymphopenia: <500/μl at 3, 6, and 12 months), patient survival (P < 0.001, hazard ratio = 5.09) and graft survival (P < 0.001, hazard ratio = 5.15) after the first year was significantly worse, and this remained to be an independent risk factor. Negative impact of persistent lymphopenia on patient and graft survival was significant regardless of type of intestinal graft. Infection leading to mortality occurred more frequently in the persistent lymphopenia group (43% vs. 24%). Trend of post-transplant ALC may be a strong predictive marker for long-term outcome in 1-year survivors after IIT/MVT.

KW - absolute lymphocyte count

KW - graft survival

KW - infection

KW - nutrition

KW - patient survival

UR - http://www.scopus.com/inward/record.url?scp=84940797192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940797192&partnerID=8YFLogxK

U2 - 10.1111/tri.12620

DO - 10.1111/tri.12620

M3 - Article

VL - 28

SP - 1195

EP - 1204

JO - Transplant International

JF - Transplant International

SN - 0934-0874

IS - 10

ER -